Evidence-based psychological and pharmacological interventions for perinatal mood and anxiety disorders

Presented by Ajeng Puspitasari, PhD, LP, ABPP, and Hemalatha Rajanna, MD

View slides from this presentation

Perinatal mood and anxiety disorder (PMAD) is not only debilitating for women during pregnancy and the first 12 months postpartum, but can lead to socioeconomic burden, suicidal behaviors, and negative impacts on children and partners. Though evidence-based treatments exist, up to 86% of women experiencing PMAD do not receive the treatment they need. In this webinar, learn how to reduce barriers to treatment and increase access to care.